New wrinkles in lipoprotein lipase biology

Purpose of review We summarize recent progress on GPIHBP1, a molecule that transports lipoprotein lipase (LPL) to the capillary lumen, and discuss several newly studied molecules that appear important for the regulation of LPL activity. Recent findings LPL, the enzyme responsible for the lipolytic processing of triglyceride-rich lipoproteins, interacts with multiple proteins and is regulated at multiple levels. Several regulators of LPL activity have been known for years and have been investigated thoroughly, but several have been identified only recently, including an endothelial cell protein that transports LPL to the capillary lumen, a microRNA that reduces LPL transcript levels, a sorting protein that targets LPL for uptake and degradation, and a transcription factor that increases the expression of apolipoproteins that regulate LPL activity. Summary Proper regulation of LPL is important for controlling the delivery of lipid nutrients to tissues. Recent studies have identified GPIHBP1 as the molecule that transports LPL to the capillary lumen, and have also identified other molecules that are potentially important for regulating LPL activity. These new discoveries open new doors for understanding basic mechanisms of lipolysis and hyperlipidemia.

[1]  S. Young,et al.  Highly Conserved Cysteines within the Ly6 Domain of GPIHBP1 Are Crucial for the Binding of Lipoprotein Lipase* , 2009, The Journal of Biological Chemistry.

[2]  R. Eckel,et al.  Spinal cord of the rat contains more lipoprotein lipase than other brain regions. , 1993, Journal of lipid research.

[3]  J. O’Connell,et al.  A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection , 2008, Science.

[4]  S. Young,et al.  The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma. , 2008, Molecular endocrinology.

[5]  M. Hayden,et al.  A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[6]  J. Polonovski,et al.  [Structure and metabolism of plasma lipoproteins]. , 1983, Pathologie-biologie.

[7]  S. Young,et al.  Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1 , 2011, Proceedings of the National Academy of Sciences.

[8]  Oliver T. Bruns,et al.  Brown adipose tissue activity controls triglyceride clearance , 2011, Nature Medicine.

[9]  M. Hayden,et al.  Presynaptic Defects Underlying Impaired Learning and Memory Function in Lipoprotein Lipase-Deficient Mice , 2009, The Journal of Neuroscience.

[10]  Junhua Ge,et al.  MicroRNA‐29a regulates pro‐inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL‐stimulated dendritic cells , 2011, FEBS letters.

[11]  G. Olivecrona,et al.  Childhood‐onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation , 2011, Journal of internal medicine.

[12]  P. Kinnunen,et al.  Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Kenichi Yoshida,et al.  ANGPTL3 Decreases Very Low Density Lipoprotein Triglyceride Clearance by Inhibition of Lipoprotein Lipase* , 2002, The Journal of Biological Chemistry.

[14]  S. Young,et al.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.

[15]  S. Young,et al.  Assessing the Role of the Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1) Three-finger Domain in Binding Lipoprotein Lipase* , 2011, The Journal of Biological Chemistry.

[16]  T. Olivecrona,et al.  Lipoprotein lipase. Mechanism of product inhibition. , 1980, European journal of biochemistry.

[17]  S. Bertolini,et al.  APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. , 2006, Current opinion in lipidology.

[18]  S. Young,et al.  Chylomicronemia With Low Postheparin Lipoprotein Lipase Levels in the Setting of GPIHBP1 Defects , 2010, Circulation. Cardiovascular genetics.

[19]  R. Eckel,et al.  Lipoprotein lipase : from gene to obesity , 2009 .

[20]  S. Deeb,et al.  Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. , 1992, Journal of lipid research.

[21]  D. Rader,et al.  Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases* , 2010, The Journal of Biological Chemistry.

[22]  C. Proud,et al.  Protein Kinase D Is a Key Regulator of Cardiomyocyte Lipoprotein Lipase Secretion After Diabetes , 2008, Circulation research.

[23]  M. Nyegaard,et al.  SorLA regulates the activity of lipoprotein lipase by intracellular trafficking , 2011, Journal of Cell Science.

[24]  D. Lougson,et al.  Acute. , 2020, The Manchester medical gazette.

[25]  T. Olivecrona,et al.  Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.

[26]  E. Lefai,et al.  GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. , 2011, The Journal of clinical endocrinology and metabolism.

[27]  A. Catapano Apolipoprotein C-II and lipoprotein lipase activity , 1982, La Ricerca in clinica e in laboratorio.

[28]  K. Holmstrøm,et al.  Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. , 2010, Human immunology.

[29]  S. Young,et al.  GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons , 2007, Current opinion in lipidology.

[30]  S. Young,et al.  The Acidic Domain of GPIHBP1 Is Important for the Binding of Lipoprotein Lipase and Chylomicrons* , 2008, Journal of Biological Chemistry.

[31]  L. Pennacchio,et al.  Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[33]  P. Puthanveetil,et al.  Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase–Dependent Actin Cytoskeleton Organization , 2008, Diabetes.

[34]  F. Wang,et al.  Severity of Diabetes Governs Vascular Lipoprotein Lipase by Affecting Enzyme Dimerization and Disassembly , 2011, Diabetes.

[35]  P. Madsen,et al.  The sortilin cytoplasmic tail conveys Golgi–endosome transport and binds the VHS domain of the GGA2 sorting protein , 2001, The EMBO journal.

[36]  M. Hayden,et al.  A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase. , 1996, Biochemical and biophysical research communications.

[37]  S. Young,et al.  GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. , 2010, Cell metabolism.

[38]  S. Young,et al.  Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice* , 2008, Journal of Biological Chemistry.

[39]  B. Rodrigues,et al.  Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[40]  R. Norum,et al.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. , 1986, The Journal of clinical investigation.

[41]  T. Olivecrona,et al.  Localization of lipoprotein lipase to discrete areas of the guinea pig brain , 1990, Brain Research.

[42]  R. Eckel,et al.  Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. , 2011, Cell metabolism.

[43]  C. Chang,et al.  Synthesis and regulation of lipoprotein lipase in the hippocampus. , 1990, Journal of lipid research.

[44]  R. Hegele,et al.  The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism , 2011, Nature Medicine.

[45]  M. Hayden,et al.  Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia , 2010, Journal of Lipid Research.

[46]  R. Hegele,et al.  Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650) , 2007, Lipids in health and disease.

[47]  C. Bunker,et al.  Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. , 2002, Atherosclerosis.

[48]  T. Kirchgessner,et al.  Localization of lipoprotein lipase mRNA in selected rat tissues. , 1989, Journal of lipid research.

[49]  A. Tanigami,et al.  CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. , 2001, Nucleic acids research.

[50]  W. Kohr,et al.  Cloning and expression of human apolipoprotein D cDNA. , 1986, The Journal of biological chemistry.

[51]  F. Toledo,et al.  A role of apolipoprotein D in triglyceride metabolism[S] , 2010, Journal of Lipid Research.

[52]  P. Alaupovic,et al.  Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. , 1976, Biochemistry.

[53]  Sanjoy Ghosh,et al.  Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. , 2003, Journal of molecular and cellular cardiology.

[54]  C. Fraser,et al.  Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.

[55]  R. Havel,et al.  Significance of lipoprotein lipase in rat skeletal muscle. , 1977, Advances in experimental medicine and biology.

[56]  T. Olivecrona,et al.  The Ins and Outs of Adipose Tissue , 2009 .

[57]  F. Wang,et al.  Cleavage of Protein Kinase D After Acute Hypoinsulinemia Prevents Excessive Lipoprotein Lipase–Mediated Cardiac Triglyceride Accumulation , 2009, Diabetes.

[58]  R. Havel,et al.  The significance of lipoprotein lipase in rat skeletal muscles. , 1977, Journal of lipid research.

[59]  S. Young,et al.  Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[60]  J. Nyengaard,et al.  Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA , 2007, Molecular and Cellular Biology.